May 10 |
Down -19.72% in 4 Weeks, Here's Why You Should You Buy the Dip in Adverum Biotechnologies (ADVM)
|
May 9 |
Adverum Biotechnologies GAAP EPS of -$1.50
|
May 9 |
Adverum Biotechnologies Reports First Quarter 2024 Financial Results and Provides Pipeline Highlights
|
May 9 |
Are Medical Stocks Lagging Ligand Pharmaceuticals (LGND) This Year?
|
May 3 |
Adverum Biotechnologies to Participate in Upcoming May Investor Conferences
|
May 2 |
Adverum Biotechnologies (ADVM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
|
May 1 |
Adverum Biotechnologies a new buy at H.C. Wainwright on wet AMD gene therapy
|
Apr 25 |
Adverum Biotechnologies to Present LUNA 26-week Phase 2 Interim Analysis at the ASRS Annual Scientific Meeting
|
Apr 23 |
Has Adverum Biotechnologies (ADVM) Outpaced Other Medical Stocks This Year?
|
Apr 19 |
Down -24.41% in 4 Weeks, Here's Why You Should You Buy the Dip in Adverum Biotechnologies (ADVM)
|